Hematological complications and quality of life in hospitalized AIDS patients

被引:15
作者
Cosby, C [1 ]
Holzemer, WL [1 ]
Henry, SB [1 ]
Portillo, CJ [1 ]
机构
[1] Univ Calif San Francisco, Sch Nursing, Dept Community Hlth Syst, San Francisco, CA 94143 USA
关键词
D O I
10.1089/108729100317731
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
The relationships among the biological and physiological indicators of cytopenias in AIDS and measures of quality of life are not well characterized. The purpose of this secondary analysis was to determine the relationships among anemia, neutropenia and thrombocytopenia and characteristics of the individual, physiological markers, symptoms, functional status, general health perceptions, and well-being in people with AIDS. The five dimensions of the Wilson and Cleary model of health-related quality of life provided the conceptual model for this study. In addition to descriptive statistics, logistic regression was used to analyze clusters of variables. The sample of 146 hospitalized patients with AIDS had an 85% prevalence of anemia, a 53% prevalence neutropenia and a 33% prevalence of thrombocytopenia. The mean age was 38 years old, 19% were female, 35% were white, 27% had a history of injection drug use and the mean T-helper cell count was 74 mm(3). The five dimensions of the Wilson and Cleary model offered significant predictability for anemia only. Patients with higher symptom scores were more likely to have treatable anemia, defined as a hematocrit of <30%. Treatable anemia was also associated with lower self-care scores and lower T-helper cells. Fifty-four percent of the cohort were candidates for colony stimulating factors, while only 17% of those eligible received them. These data suggest suboptimal treatment of anemia and neutropenia in this cohort of AIDS patients.
引用
收藏
页码:269 / 279
页数:11
相关论文
共 22 条
[1]
EFFECT OF ANTIVIRAL TREATMENTS ON THE BONE-MARROW IN MURINE AIDS [J].
BRANDI, G ;
CARNEVALI, A ;
ROSSI, L ;
FRATERNALE, A ;
SCHIAVANO, GF ;
MAGNANI, M .
BLOOD CELLS MOLECULES AND DISEASES, 1995, 21 (02) :109-118
[2]
*CDC, 1997, MMWR-MORBID MORTAL W, V46, P165
[3]
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P861
[4]
Cosby C, 1998, 12 WORLD AIDS C, P1026
[5]
INFECTION AND REPLICATION OF HIV-1 IN PURIFIED PROGENITOR CELLS OF NORMAL HUMAN-BONE MARROW [J].
FOLKS, TM ;
KESSLER, SW ;
ORENSTEIN, JM ;
JUSTEMENT, JS ;
JAFFE, ES ;
FAUCI, AS .
SCIENCE, 1988, 242 (4880) :919-922
[6]
Hambleton J, 1996, Oncology (Williston Park), V10, P671
[7]
THE HIV QUALITY AUDIT MARKER (HIV-QAM) - AN OUTCOME MEASURE FOR HOSPITALIZED AIDS PATIENTS [J].
HOLZEMER, WL ;
HENRY, SB ;
STEWART, A ;
JANSONBJERKLIE, S .
QUALITY OF LIFE RESEARCH, 1993, 2 (02) :99-107
[8]
HOLZEMER WL, IN PRESS VALIDATION
[9]
Lubeck D P, 1992, Qual Life Res, V1, P359, DOI 10.1007/BF00704430
[10]
Anemia and survival in HIV infection [J].
Moore, RD ;
Keruly, JC ;
Chaisson, RE .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (01) :29-33